BaseLaunch is excited to announce the extension of the partnership with CSL, a global biotech leader. Together, we’re committed to driving innovation in healthcare. CSL’s partnership with BaseLaunch reflects the company’s commitment to global collaboration by establishing a presence within research hubs and precincts around the world. We look forward to continuing our work together to shape the future of biotech.
”This will allow us to continue building relationships with highly innovative small companies with the potential to transform their ideas into ground-breaking therapies. Ultimately, our shared goal is to deliver new therapies that may address unmet medical needs for patients.
Dr. Adrian ZuercherVice President, Research Europe, CSL
About CSL:
CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, as well as vaccines to prevent influenza. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people.
Learn more here.
